These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25035926)

  • 1. Calorie restriction mimicking effects of roflumilast prevents diabetic nephropathy.
    Tikoo K; Lodea S; Karpe PA; Kumar S
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1581-6. PubMed ID: 25035926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway.
    Li C; Cai F; Yang Y; Zhao X; Wang C; Li J; Jia Y; Tang J; Liu Q
    Eur J Pharmacol; 2010 Dec; 649(1-3):382-9. PubMed ID: 20854812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy.
    Tikoo K; Singh K; Kabra D; Sharma V; Gaikwad A
    Free Radic Res; 2008 Apr; 42(4):397-404. PubMed ID: 18404539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway.
    Fang Y; Tian X; Bai S; Fan J; Hou W; Tong H; Li D
    Int J Mol Med; 2012 Jul; 30(1):85-92. PubMed ID: 22552764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy.
    Kumar GS; Kulkarni A; Khurana A; Kaur J; Tikoo K
    Chem Biol Interact; 2014 Nov; 223():125-33. PubMed ID: 25301743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast ameliorates diabetic nephropathy in rats through down-regulation of JAK/STAT signaling pathway.
    Patel P; Patel S; Chudasama P; Soni S; Raval M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3285-3297. PubMed ID: 37318524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53.
    Tikoo K; Tripathi DN; Kabra DG; Sharma V; Gaikwad AB
    FEBS Lett; 2007 Mar; 581(5):1071-8. PubMed ID: 17316625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhizic Acid Prevents Diabetic Nephropathy by Activating AMPK/SIRT1/PGC-1
    Hou S; Zhang T; Li Y; Guo F; Jin X
    J Diabetes Res; 2017; 2017():2865912. PubMed ID: 29238727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of total flavonoids extracted from the leaves of Murraya paniculata (L.) Jack on diabetic nephropathy in rats.
    Zou J; Yu X; Qu S; Li X; Jin Y; Sui D
    Food Chem Toxicol; 2014 Feb; 64():231-7. PubMed ID: 24309143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK; Reddy K; Balakumar P
    Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
    Kadian S; Mahadevan N; Balakumar P
    Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
    Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
    Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
    Das J; Sil PC
    Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats.
    Farid HA; Sayed RH; El-Shamarka ME; Abdel-Salam OME; El Sayed NS
    Inflammopharmacology; 2024 Apr; 32(2):1421-1437. PubMed ID: 37541971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nordihydroguairetic acid, a lignin, prevents oxidative stress and the development of diabetic nephropathy in rats.
    Anjaneyulu M; Chopra K
    Pharmacology; 2004 Sep; 72(1):42-50. PubMed ID: 15292654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
    Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
    Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
    Soetikno V; Watanabe K; Sari FR; Harima M; Thandavarayan RA; Veeraveedu PT; Arozal W; Sukumaran V; Lakshmanan AP; Arumugam S; Suzuki K
    Mol Nutr Food Res; 2011 Nov; 55(11):1655-65. PubMed ID: 22045654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.